137 related articles for article (PubMed ID: 11984514)
1. Dyspepsia management in primary care: a decision analysis of competing strategies.
Spiegel BM; Vakil NB; Ofman JJ
Gastroenterology; 2002 May; 122(5):1270-85. PubMed ID: 11984514
[No Abstract] [Full Text] [Related]
2. Dyspepsia management in the millennium: the death of test and treat?
Talley NJ
Gastroenterology; 2002 May; 122(5):1521-5. PubMed ID: 11984537
[No Abstract] [Full Text] [Related]
3. The role of treatment with proton pump inhibitors and anti-Helicobacter therapy in functional dyspepsia.
Veldhuyzen van Zanten SJ
Am J Gastroenterol; 2001 Oct; 96(10):2811-2. PubMed ID: 11693312
[No Abstract] [Full Text] [Related]
4. Dyspepsia: gaps between primary and secondary care.
Hungin AP
Dig Liver Dis; 2002 Apr; 34(4):243-5. PubMed ID: 12038805
[No Abstract] [Full Text] [Related]
5. Proton pump inhibitors for dyspepsia.
Vakil N
Dig Dis; 2008; 26(3):215-7. PubMed ID: 18463438
[TBL] [Abstract][Full Text] [Related]
6. Effect of implementation of a dyspepsia and Helicobacter pylori eradication guideline in primary care.
Cardin F; Zorzi M; Bovo E; Guerra C; Bandini F; Polito D; Bano F; Grion AM; Toffanin R
Digestion; 2005; 72(1):1-7. PubMed ID: 16088146
[TBL] [Abstract][Full Text] [Related]
7. Management of outpatients with dyspepsia.
Millard P; Fitzpatrick BP
J Fam Pract; 1997 Sep; 45(3):199-200. PubMed ID: 9312557
[No Abstract] [Full Text] [Related]
8. Helicobacter pylori eradication in long-term proton pump inhibitor users is highly cost-effective: economic analysis of the HELPUP trial.
Mason JM; Raghunath AS; Hungin AP; Jackson W
Aliment Pharmacol Ther; 2008 Dec; 28(11-12):1297-303. PubMed ID: 18793340
[TBL] [Abstract][Full Text] [Related]
9. Yield of endoscopy in dyspepsia and concurrent treatment with proton pump inhibitors: the blind leading the blind?
Talley NJ
Gastrointest Endosc; 2003 Jul; 58(1):89-92. PubMed ID: 12838227
[No Abstract] [Full Text] [Related]
10. [Update on current care guidelines. A current care guideline: recurrent upper gastrointestinal symptoms].
Paikka N
Duodecim; 2012; 128(22):2376-7. PubMed ID: 23342484
[TBL] [Abstract][Full Text] [Related]
11. Commentary: rabeprazole improves symptoms in patients with functional dyspepsia in Japan.
Yap PR; Mahadeva S; Goh KL
Aliment Pharmacol Ther; 2013 Nov; 38(10):1321-2. PubMed ID: 24134501
[No Abstract] [Full Text] [Related]
12. Commentary: rabeprazole improves symptoms in patients with functional dyspepsia in Japan - author's reply.
Iwakiri R
Aliment Pharmacol Ther; 2013 Nov; 38(10):1322-3. PubMed ID: 24134502
[No Abstract] [Full Text] [Related]
13. Is there any effect of sequential eradication therapy of helicobacter pylori on functional dyspepsia symptom resolution?
Sarikaya M; Filik L; Doğan Z; Ergül B
Acta Gastroenterol Belg; 2013 Dec; 76(4):448-9. PubMed ID: 24592555
[No Abstract] [Full Text] [Related]
14. Treatment of H. pylori infection: the reality.
Vakil N
Yale J Biol Med; 1998; 71(2):119-24. PubMed ID: 10378357
[TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori eradication for functional dyspepsia: what are we treating?: comment on "Helicobacter pylori eradication in functional dyspepsia".
Moayyedi P
Arch Intern Med; 2011 Nov; 171(21):1936-7. PubMed ID: 22123803
[No Abstract] [Full Text] [Related]
16. [Comparison of Helicobacter pylori eradication rate in patients with non-ulcer dyspepsia and peptic ulcer diseases according to proton pump inhibitors].
Hong EJ; Park DI; Oh SJ; Song MJ; Choi WH; Hong CH; Park JH; Kim HJ; Cho YK; Shon CI; Jeon WK; Kim BI
Korean J Gastroenterol; 2008 Aug; 52(2):80-5. PubMed ID: 19077498
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the dyspeptic patient: a cost-utility study.
Ebell MH; Warbasse L; Brenner C
J Fam Pract; 1997 Jun; 44(6):545-55. PubMed ID: 9191627
[TBL] [Abstract][Full Text] [Related]
18. Nonulcer dyspepsia and proton pump inhibitors.
Waldum HL; Martinsen TC; Brenna E
Gastroenterology; 2005 Mar; 128(3):805; author reply 805-6. PubMed ID: 15765429
[No Abstract] [Full Text] [Related]
19. Effect and cost-effectiveness of step-up versus step-down treatment with antacids, H2-receptor antagonists, and proton pump inhibitors in patients with new onset dyspepsia (DIAMOND study): a primary-care-based randomised controlled trial.
van Marrewijk CJ; Mujakovic S; Fransen GA; Numans ME; de Wit NJ; Muris JW; van Oijen MG; Jansen JB; Grobbee DE; Knottnerus JA; Laheij RJ
Lancet; 2009 Jan; 373(9659):215-25. PubMed ID: 19150702
[TBL] [Abstract][Full Text] [Related]
20. Low yield of endoscopy in patients with persistent dyspepsia taking proton pump inhibitors.
Smith T; Verzola E; Mertz H
Gastrointest Endosc; 2003 Jul; 58(1):9-13. PubMed ID: 12838213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
